In the current study, CD31 immunohistochemical staining and alginate-encapsulated tumor cell assay in vivo revealed that evident angiogenesis inhibition was observed in FILIP1LΔC103 or DDP treatment compared against the control groups. The gene discussed is PECAM1; the disease is neoplasm.